Contribution of both M1 and M4 receptors to muscarinic agonist-mediated attenuation of the cocaine discriminative stimulus in mice

Psychopharmacology

Volumn 220, Issue 4, 2012, Pages 673-685

  Thomsen, Morgane ^a   Lindsley, Craig W ^b   Conn, P Jeffrey ^b   Wessell, Jeffrey E ^a   Fulton, Brian S ^a   Wess, Jürgen ^c   Caine, S Barak ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Acetylcholine receptor; Addiction; Cocaine; Drug discrimination; Knockout; Muscarinic

Indexed keywords

1 [3 (4 BUTYL 1 PIPERIDINYL)PROPYL] 3,4 DIHYDRO 2(1H)QUINOLINONE; 77LH 28 1; BENZYLQUINOLONECARBOXYLIC ACID; COCAINE; ETHYL 4 [2 (2 METHYLBENZAMIDO)ETHYLAMINO]PIPERIDINE 1 CARBOXYLATE; ETICLOPRIDE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M4 RECEPTOR; UNCLASSIFIED DRUG; VU 0357017; XANOMELINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIARRHEA; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG EFFECT; DRUG SELECTIVITY; FEMALE; MALE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; STIMULUS RESPONSE; WILD TYPE; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DISCRIMINATION LEARNING; DRUG POTENTIATION; DRUG SELF ADMINISTRATION; INSTRUMENTAL CONDITIONING; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; COCAINE; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCARINIC AGONISTS; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M4; SELF ADMINISTRATION;

EID: 84871853550     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2516-9     Document Type: Article

References (64)

1. Alderson HL, Latimer MP, Blaha C.D., Phillips AG, Winn P. (2004) An examination of d-amphetamine self-administration in pedunculo-pontine tegmental nucleus-lesioned rats. Neuroscience 125:349-58
2. Anagnostaras SG, Murphy GG, Hamilton S.E., Mitchell SL, Rahnama NP, Nathanson NM, Silva A.J. (2003) Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 6:51-8
3. Andersen MB, Werge T, Fink-Jensen A (2007) The acetylcholinester-ase inhibitor galantamine inhibits d-amphetamine-induced psychotic-like behavior in Cebus monkeys. J Pharmacol Exp Ther 321:1179-82
4. Bechara A, van der Kooy D (1989) The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine. J Neurosci 9:3400-9
5. Bernard V, Normand E, Bloch B. (1992) Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J Neurosci 12:3591-600
6. Blaha CD, Allen LF, Das S, Inglis W.L., Latimer MP, Vincent SR, Winn P. (1996) Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J Neurosci 16:714-22
7. Bolam JP, Francis CM, Henderson Z. (1991) Cholinergic input to dopaminergic neurons in the substantia nigra: a double immuno-cytochemical study. Neuroscience 41:483-94
8. Bonsi P, Martella G, Cuomo D., Platania P, Sciamanna G, Bernardi G., Wess J, Pisani A (2008) Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum. J Neurosci 28:6258-63
9. Carrigan KA, Dykstra L.A. (2007) Behavioral effects of morphine and cocaine in M1 muscarinic acetylcholine receptor-deficient mice. Psychopharmacology (Berl) 191:985-93
10. De La Garza R 2nd, Mahoney JJ 3rd, Culbertson C, Shoptaw S, Newton TF (2008a) The acetylcholinesterase inhibitor rivastig-mine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers. Pharmacol Biochem Behav 89:200-8
11. De La Garza R, Shoptaw S, Newton TF (2008b) Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers. Int J Neuropsychopharmacol 11:729-41
12. Dencker D, Wortwein G, Weikop P., Jeon J, Thomsen M, Sager T.N., Mork A., Woldbye DP, Wess J, Fink-Jensen (2011) Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1/M4 preferring muscarinic receptor agonist xanomeline. J Neurosci 31:5905-5908
13. Di Chiara G., Morelli M, Consolo S. (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci 17:228-33
14. Eglen RM (2006) Muscarinic receptor subtypes in neuronal and nonneuronal cholinergic function. Auton Autacoid Pharmacol 26:219-33
15. Fink-Jensen A., Fedorova I, Wortwein G., Woldbye DP, Rasmussen T, Thomsen M, Bolwig T.G., Knitowski KM, McKinzie DL, Yamada M, Wess J, Basile A (2003) Role for M5 muscarinic acetylcho-line receptors in cocaine addiction. J Neurosci Res 74:91-6
16. Gomeza J, Zhang L, Kostenis E., Felder C, Bymaster F, Brodkin J., Shannon H, Xia B, Deng C, Wess J (1999) Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A 96:10483-8
17. Grasing K, He S, Yang Y. (2008) Dose-related effects of the acetylcholinesterase inhibitor tacrine on cocaine and food self-administration in rats. Psychopharmacology (Berl) 196:133-42
18. Grasing K, He S, Yang Y. (2009) Long-lasting decreases in cocaine-reinforced behavior following treatment with the cholinesterase inhibitor tacrine in rats selectively bred for drug self-administration. Pharmacol Biochem Behav 94:169-78
19. Grasing K, Mathur D, Newton T.F., DeSouza C. (2010) Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals. Drug Alcohol Depend 107:69-75
20. Hardouin SN, Richmond KN, Zimmerman A, Hamilton S.E., Feigl EO, Nathanson N.M. (2002) Altered cardiovascular responses in mice lacking the M(1) muscarinic acetylcholine receptor. J Pharmacol Exp Ther 301:129-37
21. Heinrich JN, Butera JA, Carrick T, Kramer A., Kowal D, Lock T, Marquis K.L., Pausch MH, Popiolek M, Sun SC, Tseng E, Uveges AJ, Mayer SC (2009) Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists. Eur J Pharmacol 605:53-6
22. Hersch SM, Levey A.I. (1995) Diverse pre- and post-synaptic expression of m1-m4 muscarinic receptor proteins in neurons and afferents in the rat neostriatum. Life Sci 56:931-8
23. Hersch SM, Gutekunst CA, Rees H.D., Heilman CJ, Levey A.I. (1994) Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies. J Neurosci 14:3351-63
24. Hikida T, Kaneko S, Isobe T., Kitabatake Y, Watanabe D, Pastan I., Nakanishi S. (2001) Increased sensitivity to cocaine by choliner-gic cell ablation in nucleus accumbens. Proc Natl Acad Sci U S A 98:13351-4
25. Hikida T, Kitabatake Y, Pastan I, Nakanishi S (2003) Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci U S A 100:6169-73
26. Ichikawa J, Chung YC, Li Z, Dai J., Meltzer H.Y. (2002) Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Res 958:176-84
27. Ikemoto S, Wise R.A. (2002) Rewarding effects of the cholinergic agents carbachol and neostigmine in the posterior ventral tegmental area. J Neurosci 22:9895-904
28. Jeon J, Dencker D, Wortwein G., Woldbye DP, Cui Y, Davis AA, Levey A.I., Schutz G., Sager TN, Mork A, Li C, Deng CX, Fink-Jensen A, Wess J (2010) A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors. J Neurosci 30:2396-405
29. Jones CK, Brady AE, Davis A.A., Xiang Z., Bubser M, Tantawy MN, Kane A.S., Bridges TM, Kennedy JP, Bradley SR, Peterson TE, Ansari MS, Baldwin RM, Kessler RM, Deutch AY, Lah JJ, Levey AI, Lindsley CW, Conn PJ (2008) Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats. J Neurosci 28:10422-33
30. Kane BE, Grant MK, El-Fakahany EE, Ferguson D.M. (2008) Synthesis and evaluation of xanomeline analogs-probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor. Bioorg Med Chem 16:1376-92
31. Kitabatake Y, Hikida T, Watanabe D., Pastan I, Nakanishi S. (2003) Impairment of reward-related learning by cholinergic cell ablation in the striatum. Proc Natl Acad Sci U S A 100:7965-70
32. Langmead CJ, Austin NE, Branch C.L., Brown JT, Buchanan KA, Davies CH, Forbes I.T., Fry VA, Hagan JJ, Herdon HJ, Jones GA, Jeggo R, Kew JN, Mazzali A, Melarange R, Patel N, Pardoe J, Randall AD, Roberts C, Roopun A, Starr KR, Teriakidis A, Wood MD, Whittington M, Wu Z, Watson J (2008a) Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1. Br J Pharmacol 154:1104-15
33. Langmead CJ, Watson J, Reavill C. (2008b) Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol Ther 117:232-43
34. Lebois EP, Bridges TM, Lewis L.M., Dawson ES, Kane AS, Xiang Z, Jadhav S.B., Yin H., Kennedy JP, Meiler J, Niswender CM, Jones CK, Conn PJ, Weaver CD, Lindsley CW (2009) Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M1 receptor function in the central nervous system. ACS Chemical Neurosci 1:104-121
35. Lester DB, Miller AD, Blaha C.D. (2010) Muscarinic receptor blockade in the ventral tegmental area attenuates cocaine enhancement of laterodorsal tegmentum stimulation-evoked accumbens dopamine efflux in the mouse. Synapse 64:216-23
36. Loughlin SE, Fallon J.H. (1984) Substantia nigra and ventral tegmental area projections to cortex: topography and collateralization. Neuroscience 11:425-35
37. Ma L, Seager MA, Wittmann M, Jacobson M., Bickel D, Burno M, Jones K., Graufelds VK, Xu G, Pearson M, McCampbell A, Gaspar R, Shughrue P, Danziger A, Regan C, Flick R, Pascarella D, Garson S, Doran S, Kreatsoulas C, Veng L, Lindsley CW, Shipe W, Kuduk S, Sur C, Kinney G, Seabrook GR, Ray WJ (2009) Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation. Proc Natl Acad Sci U S A 106:15950-5
38. Mark GP, Kinney AE, Grubb M.C., Zhu X., Finn DA, Mader SL, Berger SP, Bechtholt A.J. (2006) Injection of oxotremorine in nucleus accumbens shell reduces cocaine but not food self-administration in rats. Brain Res 1123:51-9
39. Miyakawa T, Yamada M, Duttaroy A., Wess J. (2001) Hyperactiv-ity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 21:5239-50
40. Oakman SA, Faris PL, Kerr P.E., Cozzari C., Hartman B.K. (1995) Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci 15:5859-69
41. Olmstead MC, Franklin K.B. (1993) Effects of pedunculopontine tegmental nucleus lesions on morphine-induced conditioned place preference and analgesia in the formalin test. Neuroscience 57:411-8
42. Raffa RB (2009) The M5 muscarinic receptor as possible target for treatment of drug abuse. J Clin Pharm Ther 34:623-9
43. Sauerberg P, Olesen PH, Nielsen S, Treppendahl S., Sheardown MJ, Honore T, Mitch CH, Ward J.S., Pike AJ, Bymaster FP et al (1992) Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1, 2, 5-thiadiazolyl)-1, 2, 5, 6-tetrahydro-1-methylpyridines. J Med Chem 35:2274-83
44. Schmidt LS, Thomsen M, Weikop P., Dencker D, Wess J, Woldbye D.P., Wortwein G., Fink-Jensen A (2011) Increased cocaine self-administration in M(4) muscarinic acetylcholine receptor knockout mice. Psychopharmacology (Berl). doi:10.1007/s00213-011-2225-4
45. Shabani S, Foster R, Gubner N., Phillips TJ, Mark G.P. (2010) Muscarinic type 2 receptors in the lateral dorsal tegmental area modulate cocaine and food seeking behavior in rats. Neuroscience 170:559-69
46. Shannon HE, Bymaster FP, Calligaro D.O., Greenwood B., Mitch CH, Sawyer BD, Ward JS, Wong D.T., Olesen PH, Sheardown MJ et al (1994) Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors. J Pharmacol Exp Ther 269:271-81
47. Shirey JK, Brady AE, Jones P.J., Davis AA, Bridges TM, Kennedy JP, Jadhav S.B., Menon UN, Xiang Z, Watson ML, Christian EP, Doherty JJ, Quirk MC, Snyder DH, Lah JJ, Levey AI, Nicolle MM, Lindsley CW, Conn PJ (2009) A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning. J Neurosci 29:14271-86
48. Smiley JF, Levey AI, Mesulam M.M. (1999) m2 muscarinic receptor immunolocalization in cholinergic cells of the monkey basal forebrain and striatum. Neuroscience 90:803-14
49. Smith JE, Co C, Yin X., Sizemore GM, Liguori A, Johnson WE 3rd, Martin TJ (2004) Involvement of cholinergic neuronal systems in intravenous cocaine self-administration. Neurosci Biobehav Rev 27:841-50
50. Sofuoglu M, Mooney M. (2009) Cholinergic functioning in stimulant addiction: implications for medications development. CNS Drugs 23:939-52
51. Takamatsu Y, Yamanishi Y, Hagino Y., Yamamoto H, Ikeda K. (2006) Differential effects of donepezil on methamphetamine and cocaine dependencies. Ann N Y Acad Sci 1074:418-26
52. Tanda G, Ebbs AL, Kopajtic T.A., Elias LM, Campbell BL, Newman AH, Katz J.L. (2007) Effects of muscarinic M1 receptor blockade on cocaine-induced elevations of brain dopamine levels and locomotor behavior in rats. J Pharmacol Exp Ther 321:334-44
53. Thomsen M, Woldbye DP, Wortwein G, Fink-Jensen A, Wess J., Caine S.B. (2005) Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. J Neu-rosci 25:8141-9
54. Thomsen M, Conn PJ, Lindsley C, Wess J., Boon JY, Fulton BS, Fink-Jensen A, Caine S.B. (2010) Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetyl-choline receptor stimulation. J Pharmacol Exp Ther 332:959-69
55. Threlfell S, Clements MA, Khodai T, Pienaar I.S., Exley R., Wess J, Cragg S.J. (2010) Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J Neurosci 30:3398-408
56. Vilaro MT, Palacios JM, Mengod G. (1990) Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neurosci Lett 114:154-9
57. Weiner DM, Levey AI, Brann M.R. (1990) Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci U S A 87:7050-4
58. Wess J (2004) Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 44:423-50
59. Williams MJ, Adinoff B. (2008) The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 33:1779-97
60. Winhusen TM, Somoza EC, Harrer J.M., Mezinskis JP, Montgomery MA, Goldsmith RJ, Coleman F.S., Bloch DA, Leiderman DB, Singal BM, Berger P, Elkashef A (2005) A placebo-controlled screening trial of tiagabine, sertraline and donepe-zil as cocaine dependence treatments. Addiction 100(SUPPL. 1):68-77
61. Yeomans J, Baptista M. (1997) Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward. Pharmacol Biochem Behav 57:915-21
62. Yeomans JS, Kofman O, McFarlane V. (1985) Cholinergic involvement in lateral hypothalamic rewarding brain stimulation. Brain Res 329:19-26
63. Yeomans JS, Takeuchi J, Baptista M., Flynn DD, Lepik K, Nobrega J, Fulton J., Ralph M.R. (2000) Brain-stimulation reward thresholds raised by an antisense oligonucleotide for the M5 muscarinic receptor infused near dopamine cells. J Neurosci 20:8861-7
64. You ZB, Wang B, Zitzman D., Wise R.A. (2008) Acetylcholine release in the mesocorticolimbic dopamine system during cocaine seeking: conditioned and unconditioned contributions to reward and motivation. J Neurosci 28:9021-9